IL132682A - Medicinal preparations for topical treatment - Google Patents

Medicinal preparations for topical treatment

Info

Publication number
IL132682A
IL132682A IL13268298A IL13268298A IL132682A IL 132682 A IL132682 A IL 132682A IL 13268298 A IL13268298 A IL 13268298A IL 13268298 A IL13268298 A IL 13268298A IL 132682 A IL132682 A IL 132682A
Authority
IL
Israel
Prior art keywords
topical composition
composition according
pharmacologically active
eutectic
pharmaceutically acceptable
Prior art date
Application number
IL13268298A
Other languages
English (en)
Hebrew (he)
Other versions
IL132682A0 (en
Original Assignee
Galen Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galen Chemicals Ltd filed Critical Galen Chemicals Ltd
Publication of IL132682A0 publication Critical patent/IL132682A0/xx
Publication of IL132682A publication Critical patent/IL132682A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
IL13268298A 1997-05-14 1998-05-14 Medicinal preparations for topical treatment IL132682A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE970346 1997-05-14
PCT/IE1998/000036 WO1998051283A1 (fr) 1997-05-14 1998-05-14 Compositions topiques

Publications (2)

Publication Number Publication Date
IL132682A0 IL132682A0 (en) 2001-03-19
IL132682A true IL132682A (en) 2004-06-20

Family

ID=11041469

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13268298A IL132682A (en) 1997-05-14 1998-05-14 Medicinal preparations for topical treatment

Country Status (15)

Country Link
US (1) US6841161B1 (fr)
EP (1) EP0981330B1 (fr)
JP (1) JP2001525820A (fr)
CN (1) CN1255850A (fr)
AT (1) ATE221770T1 (fr)
AU (1) AU734429B2 (fr)
CA (1) CA2289966A1 (fr)
DE (1) DE69807065T2 (fr)
DK (1) DK0981330T3 (fr)
ES (1) ES2182309T3 (fr)
IL (1) IL132682A (fr)
NO (1) NO995573L (fr)
NZ (1) NZ501235A (fr)
PT (1) PT981330E (fr)
WO (1) WO1998051283A1 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6299902B1 (en) 1999-05-19 2001-10-09 The University Of Georgia Research Foundation, Inc. Enhanced transdermal anesthesia of local anesthetic agents
US6368618B1 (en) * 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
TWI277418B (en) * 2001-06-18 2007-04-01 Noven Pharma Enhanced drug delivery in transdermal systems
US6528076B2 (en) * 2001-07-06 2003-03-04 Magic Herb Corp. Topical compositions and methods for treating pain
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20060241175A1 (en) * 2002-09-27 2006-10-26 Joseph Schwarz Vehicle for topical delivery of anti-inflammatory compounds
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
WO2004110458A1 (fr) * 2003-05-16 2004-12-23 Board Of Regents, The University Of Texas System Enantiomeres de phenothiazine utiles comme agents de prevention de la perte osseuse
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
DE102004001093A1 (de) * 2004-01-05 2005-07-28 Liedtke, Rainer K., Dr. Zusammensetzung und Methode einer synergistischen topischen Therapie neuromuskulärer Schmerzen
JP5148271B2 (ja) 2004-06-02 2013-02-20 ニューロジズエックス,インコーポレーテッド 疼痛処置のためのカプサイシノイド、局所麻酔薬および/または鎮痒薬を含有する処方物
US20070048360A1 (en) * 2005-08-23 2007-03-01 R Carrara Dario N Pharmaceutical compositions with melting point depressant agents and method of making same
WO2007044693A2 (fr) * 2005-10-07 2007-04-19 The University Of Alabama Compositions liquides, ioniques, multifonctionnelles pour vaincre le polymorphisme et conferer de meilleures proprietes a des ingredients actifs pharmaceutiques, biologiques, nutritionnels et energetiques
US20070224261A1 (en) * 2006-03-22 2007-09-27 Peter Draper Eutectic liquid drug formulation
US20080255103A1 (en) * 2007-04-12 2008-10-16 Ballay Pharmaceuticals, Inc. Antihistamine and anti-nausea pharmaceutical compositions for topical application
MX2010005590A (es) 2007-12-06 2010-06-08 Unilever Nv Composicion para el cuidado personal.
MX2010005589A (es) 2007-12-06 2010-06-02 Unilever Nv Composicion para el cuidado personal.
US20110092493A1 (en) * 2008-09-24 2011-04-21 Clark Levi Dose-controlled transdermal promethazine compositions and methods of use
AU2010336441B2 (en) 2009-12-23 2015-02-05 Nuvo Research Inc. Highly permeating terbinafine formulation for treating onychomycosis
US8535692B2 (en) * 2010-04-21 2013-09-17 Teikoku Pharma Usa, Inc. Local anesthetic emulsion compositions and methods of making and using the same
WO2012079232A1 (fr) * 2010-12-15 2012-06-21 Lai Hung-Cheng Composés utilisés pour traiter le cancer et utilisation associée compounds used for treating cancer and the use thereof
GB201113662D0 (en) * 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
WO2014123100A1 (fr) * 2013-02-05 2014-08-14 リンテック株式会社 Anesthésique topique de type timbre
CN104548070B (zh) * 2015-01-19 2016-08-24 常州亚当生物技术有限公司 复方辣椒碱乳剂在治疗皮肤创伤的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5206021A (en) * 1988-05-09 1993-04-27 Rhone-Poulenc Ag Company Stabilized oil-in-water emulsions or suspoemulsions containing pesticidal substances in both oil and water phases
GB8921710D0 (en) 1989-09-26 1989-11-08 Mentholatum Co Ltd Ibuprofen triturates and topical compositions containing same
WO1991008670A1 (fr) * 1989-12-11 1991-06-27 Vincent Henry Guerrini Composition pesticide comprenant de l'azadirachtine, du dialkyltoluamide et de l'huile (de geranium et/ou de la citronelle)
US5525597A (en) * 1993-12-14 1996-06-11 Kalamazoo Holdings, Inc. Synergistic insecticidal compositions comprising capsicum and insecticidal use thereof
TW460296B (en) * 1994-09-01 2001-10-21 Janssen Pharmaceutica Nv Topical ketoconazole emulsion compositions without sodium sulfite
US6251405B1 (en) * 1995-06-07 2001-06-26 Connaught Laboratories, Inc. Immunological combination compositions and methods
US5658583A (en) 1995-07-28 1997-08-19 Zhang; Jie Apparatus and methods for improved noninvasive dermal administration of pharmaceuticals

Also Published As

Publication number Publication date
AU7545698A (en) 1998-12-08
CN1255850A (zh) 2000-06-07
CA2289966A1 (fr) 1998-11-19
NO995573L (no) 2000-01-14
IL132682A0 (en) 2001-03-19
DE69807065D1 (de) 2002-09-12
ATE221770T1 (de) 2002-08-15
NZ501235A (en) 2001-06-29
EP0981330A1 (fr) 2000-03-01
AU734429B2 (en) 2001-06-14
WO1998051283A1 (fr) 1998-11-19
PT981330E (pt) 2002-12-31
ES2182309T3 (es) 2003-03-01
US6841161B1 (en) 2005-01-11
DE69807065T2 (de) 2003-05-08
JP2001525820A (ja) 2001-12-11
NO995573D0 (no) 1999-11-12
EP0981330B1 (fr) 2002-08-07
DK0981330T3 (da) 2002-12-02

Similar Documents

Publication Publication Date Title
EP0981330B1 (fr) Compositions topiques
KR100303095B1 (ko) 알릴 아민 화합물을 함유하는 국소용 약학 조성물
KR100339793B1 (ko) 외용항염증제
DE68907312T2 (de) Bunazosin oder seine Salze enthaltende pharmazeutische Zubereitungen zur perkutanen Verabreichung.
DE68907081T2 (de) Mittel mit erhöhtem Penetrationsvermögen.
US8609733B2 (en) Sensory-specific local anesthesia and prolonged duration local anesthesia
EP0473810B1 (fr) Préparations à usage externe contenant de l'eau et du propionate de déprodone
DE69001734T2 (de) Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.
EP0453603B1 (fr) Compositions pharmaceutiques contenant du piroxicam pour application topique
US20230059107A1 (en) Stable topical compositions of fenoldopam
KR20220134617A (ko) 개선된 전달 및 혈장 반감기를 갖는 국소 로플루밀라스트 제형
JPH0735332B2 (ja) 外用クリ−ム製剤
EP3666254A2 (fr) Composition pharmaceutique contenant un (r)-n-[1-(3,5-difluoro-4-méthanesulfonylamino-phényl)-éthyl]-3-(2-propyl-6-trifluorométhyl-pyridin-3-yl)-acrylamide
WO2007086582A1 (fr) LOTION EN ÉMULSION DE TYPE HUILE DANS L'EAU CONTENANT DE LA 22-OXA-1α,25-DIHYDROXYVITAMINE D3 ET MÉTHODE DE TRAITEMENT D'UNE MALADIE CUTANÉE UTILISANT LADITE LOTION
WO2023016583A1 (fr) Composition de ruxolitinib et utilisation associée
JP2935113B1 (ja) インドメタシン経皮吸収剤
US20230181591A1 (en) Stable formulations of shr0302
KR100216623B1 (ko) 비스테로이드성 소염진통제의 외용약제 조성물
LV11966B (en) ANTI-FRAUD MEASURE FOR EXTERNAL USE
JPH02142727A (ja) 消炎鎮痛外用クリーム製剤
KR19990008108A (ko) 에메다스틴을 함유하는 외용제
MXPA02001351A (en) Topical use of anti-muscarinic agents

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees